Pharmacological Characterization of Toludesvenlafaxine as a Triple Reuptake Inhibitor
Toludesvenlafaxine hydrochloride dihydrate is a novel chemical entity and a potential triple monoamine reuptake inhibitor. This study characterized the in vitro triple reuptake inhibition activity, antidepressant-like activity in animals, and pharmacokinetic profiles in rats of toludesvenlafaxine. B...
Saved in:
Main Authors: | Haibo Zhu (Author), Wenyan Wang (Author), Chunjie Sha (Author), Wei Guo (Author), Chunmei Li (Author), Fengjuan Zhao (Author), Hongbo Wang (Author), Wanglin Jiang (Author), Jingwei Tian (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of triple reuptake inhibitor toludesvenlafaxine on neurological function in cerebral ischemic rats
by: Xiaohui Sun, et al.
Published: (2023) -
LPM580098, a Novel Triple Reuptake Inhibitor of Serotonin, Noradrenaline, and Dopamine, Attenuates Neuropathic Pain
by: Nannan Li, et al.
Published: (2019) -
Epigenetic Mechanism of 5-HT/NE/DA Triple Reuptake Inhibitor on Adult Depression Susceptibility in Early Stress Mice
by: Ping Meng, et al.
Published: (2022) -
Subacute toxicity evaluations of LPM3480392 in rats, a full µ-opioid receptor biased agonist
by: Liang Ye, et al.
Published: (2023) -
PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo
by: Fangfang Li, et al.
Published: (2020)